INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
NYSE:INSP - US4577301090 - Common Stock
90.44 USD
-1.86 (-2.02%)
We assign a fundamental rating of 6 out of 10 to INSP. INSP was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While INSP has a great health rating, its profitability is only average at the moment. INSP is not overvalued while it is showing excellent growth. This is an interesting combination. This makes INSP very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
INSP had a positive operating cash flow in the past year.
In the past 5 years INSP reported 4 times negative net income.
In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
INSP's Return On Assets of 6.62% is amongst the best of the industry. INSP outperforms 85.95% of its industry peers.
INSP's Return On Equity of 7.84% is amongst the best of the industry. INSP outperforms 80.54% of its industry peers.
With a decent Return On Invested Capital value of 5.35%, INSP is doing good in the industry, outperforming 77.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| ROIC | 5.35% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 6.17%, INSP is doing good in the industry, outperforming 76.76% of the companies in the same industry.
The Operating Margin of INSP (4.81%) is better than 68.65% of its industry peers.
Looking at the Gross Margin, with a value of 84.47%, INSP belongs to the top of the industry, outperforming 94.59% of the companies in the same industry.
INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.81% | ||
| PM (TTM) | 6.17% | ||
| GM | 84.47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INSP is destroying value.
INSP has more shares outstanding than it did 1 year ago.
INSP has more shares outstanding than it did 5 years ago.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 14.62 indicates that INSP is not in any danger for bankruptcy at the moment.
INSP has a Altman-Z score of 14.62. This is amongst the best in the industry. INSP outperforms 94.05% of its industry peers.
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 14.62 |
ROIC/WACC0.6
WACC8.9%
2.3 Liquidity
A Current Ratio of 6.14 indicates that INSP has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 6.14, INSP belongs to the top of the industry, outperforming 82.16% of the companies in the same industry.
INSP has a Quick Ratio of 4.84. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP has a Quick ratio of 4.84. This is in the better half of the industry: INSP outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.14 | ||
| Quick Ratio | 4.84 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1177.78% over the past year.
Looking at the last year, INSP shows a very strong growth in Revenue. The Revenue has grown by 22.05%.
The Revenue has been growing by 57.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.82%
3.2 Future
Based on estimates for the next years, INSP will show a very strong growth in Earnings Per Share. The EPS will grow by 27.86% on average per year.
INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.85% yearly.
EPS Next Y-70.47%
EPS Next 2Y-5%
EPS Next 3Y14.99%
EPS Next 5Y27.86%
Revenue Next Year13.13%
Revenue Next 2Y13.73%
Revenue Next 3Y14.08%
Revenue Next 5Y14.85%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 39.32, the valuation of INSP can be described as expensive.
Based on the Price/Earnings ratio, INSP is valued a bit cheaper than the industry average as 70.81% of the companies are valued more expensively.
INSP's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.14.
A Price/Forward Earnings ratio of 57.93 indicates a quite expensive valuation of INSP.
Based on the Price/Forward Earnings ratio, INSP is valued a bit cheaper than the industry average as 66.49% of the companies are valued more expensively.
INSP's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.80.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.32 | ||
| Fwd PE | 57.93 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 67.57% of the companies listed in the same industry.
80.54% of the companies in the same industry are more expensive than INSP, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.46 | ||
| EV/EBITDA | 42.82 |
4.3 Compensation for Growth
A more expensive valuation may be justified as INSP's earnings are expected to grow with 14.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5%
EPS Next 3Y14.99%
5. Dividend
5.1 Amount
INSP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:INSP (8/28/2025, 2:36:25 PM)
90.44
-1.86 (-2.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.52%
Inst Owner Change-1.82%
Ins Owners0.94%
Ins Owner Change0.37%
Market Cap2.67B
Analysts79.23
Price Target151.2 (67.18%)
Short Float %9.03%
Short Ratio2.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)127.01%
Min EPS beat(2)114.53%
Max EPS beat(2)139.49%
EPS beat(4)4
Avg EPS beat(4)247.35%
Min EPS beat(4)54.07%
Max EPS beat(4)681.29%
EPS beat(8)8
Avg EPS beat(8)257.08%
EPS beat(12)12
Avg EPS beat(12)187.32%
EPS beat(16)16
Avg EPS beat(16)150.49%
Revenue beat(2)1
Avg Revenue beat(2)0.22%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)1.13%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)8
Avg Revenue beat(12)2.61%
Revenue beat(16)12
Avg Revenue beat(16)3.81%
PT rev (1m)-31.23%
PT rev (3m)-31.85%
EPS NQ rev (1m)-77.07%
EPS NQ rev (3m)-80.68%
EPS NY rev (1m)-77.9%
EPS NY rev (3m)-77.9%
Revenue NQ rev (1m)-7.4%
Revenue NQ rev (3m)-7.98%
Revenue NY rev (1m)-4.71%
Revenue NY rev (3m)-4.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.32 | ||
| Fwd PE | 57.93 | ||
| P/S | 3.1 | ||
| P/FCF | 31.46 | ||
| P/OCF | 22.77 | ||
| P/B | 3.95 | ||
| P/tB | 3.95 | ||
| EV/EBITDA | 42.82 |
EPS(TTM)2.3
EY2.54%
EPS(NY)1.56
Fwd EY1.73%
FCF(TTM)2.87
FCFY3.18%
OCF(TTM)3.97
OCFY4.39%
SpS29.13
BVpS22.92
TBVpS22.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| ROCE | 5.84% | ||
| ROIC | 5.35% | ||
| ROICexc | 9.29% | ||
| ROICexgc | 9.29% | ||
| OM | 4.81% | ||
| PM (TTM) | 6.17% | ||
| GM | 84.47% | ||
| FCFM | 9.87% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score7
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 300.74% | ||
| Cap/Sales | 3.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 225.05% | ||
| Profit Quality | 160.03% | ||
| Current Ratio | 6.14 | ||
| Quick Ratio | 4.84 | ||
| Altman-Z | 14.62 |
F-Score7
WACC8.9%
ROIC/WACC0.6
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
EPS Next Y-70.47%
EPS Next 2Y-5%
EPS Next 3Y14.99%
EPS Next 5Y27.86%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.82%
Revenue Next Year13.13%
Revenue Next 2Y13.73%
Revenue Next 3Y14.08%
Revenue Next 5Y14.85%
EBIT growth 1Y389.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year687.25%
EBIT Next 3Y123.87%
EBIT Next 5Y79.05%
FCF growth 1Y348.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y245.22%
OCF growth 3YN/A
OCF growth 5YN/A